Summit Partners Makes Growth Investment in Dreampath Diagnostics

StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS

August 13, 2025

Medical Devices

StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.

Sunrise Acquires Dreem Health to Expand U.S. Sleep Care Presence

December 12, 2024

Healthcare Services

Belgium-based sleep diagnostics company Sunrise has acquired California-based virtual sleep clinic Dreem Health to accelerate its U.S. expansion and add telehealth diagnosis and treatment capabilities. By pairing Sunrise's at-home sleep testing technology with Dreem Health's licensed providers and insurer partnerships, Sunrise aims to scale nationwide access to sleep care.

StageBio Acquires TPL Path Labs

October 21, 2020

Healthcare Services

StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.

InTandem Capital Partners Invests in Clinilabs

March 12, 2025

Healthcare Services

InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.

SourceBio International plc Acquires LDPath Limited

March 29, 2022

Healthcare Services

SourceBio International plc has completed a strategic acquisition of LDPath Limited, a London-based digital pathology testing provider. The deal expands SourceBio's digital and AI-enabled pathology capabilities and creates a larger private provider of cellular and digital pathology services for the U.K. healthcare market.

Versant Diagnostics Acquires Two Chicago-Area Pathology Practices

July 11, 2022

Healthcare Services

Versant Diagnostics, a PE-backed independent physician services company, acquired Pathology Consultants of Chicago and the operating assets of Elgin Laboratory Physicians to expand its footprint in the greater-Chicago market. The deals (Versant's third and fourth acquisitions in nine months) support the company's strategy to consolidate pathology practices and accelerate digital pathology conversion with growth capital backing from Iron Path Capital and financing support from Principal.